|
|
|
|
|
 |
Home |
 | |
 |
Calendar |
| |
|
Video |
| |
|
FAQs |
| |
|
Resources |
| |
| Upcoming Special Events | | |
|
|
|
|
Thank you to Providence Saint Joseph Foundation for providing funding for this site.
For more information about funding opportunities please contact the Foundation at
818-847-4673.
To earn CME Credits, please read our FAQ's.
I have read the FAQ's and need to Register.
I'm registered and need to LOGIN.
The AMA now requires that enduring materials, such as the Providence CME website, provide an assessment of the learner that measures achievement of purpose/objectives with minimum performance level required for credit. Therefore, a post-test must now be completed in order to receive AMA PRA Category 1 Credit™ for viewing videos on this site.
A score of 3 out of 3 or 100% answered correctly will be required to receive credit. Changes are effective for all activities that occur or are released on or after July 1, 2011.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please note: CME credit for videos expires one year after posting date, unless otherwise noted.
A bibliography for each topic is available by contacting the Health Science Library at 818-847-3822 .
|
|
The Path to Personalized Medicine in IBD
TUESDAY, April 9, 2019
12:15pm--Hope Conference Center
THE PATH TO PERSONALIZED MEDICINE IN IBD
DERMOT P.B. MCGOVERN, MD, PHD, MRCP
DIRECTOR, TRANSLATIONAL MEDICINE
F. WIDJAJA FOUNDATION INFLAMMATORY BOWEL AND IMMUNOBIOLOGY RESEARCH
INSTITUTE, CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Ora Gordon, MD, MS; Regional Medical Director, Center for Clinical Genetics & Genomics; Medical Director, Integrative Medicine, Roy and Patricia Disney Family Cancer Center, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements with any commercial company to disclose. Dr. McGovern discloses he is a consultant for Precision IBD, Gilead, Janssen, Bridge Therapeutics, Qu Biologics, and Pfizer, and has received grant support from Janssen and Second Genome. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:
This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
|
|
4/9/2019
|
|
Dermot
McGovern,
MD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
Complete Video Confirmation
In order to complete the evaluation, you must log in.
|
|
|
|
Diagnosis and Management of Rheumatoid Arthritis
|
|
TUESDAY, March 19, 2019
12:15pm—Hope Conference Center
DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS
PENG FAN, MD
CLINICAL PROFESSOR OF MEDICINE, DIVISION OF RHEUMATOLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai states he has no financial arrangements with any commercial company to disclose. Dr. Fan discloses he is on the Speakers Bureau for Amgen, Novartis, Pfizer, Sanofi, Genzyme, Abbrie, Radius, Regeneron. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:
This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
|
|
|
|
|
|
|
|
|
|
|